EFFECTS OF SILVER NANOPARTICLES ON THYROID GLAND STRUCTURE AND FUNCTION IN FEMALE RATS

Amal A Sulaiman; Noori M Luaibi; Hiba A Qassim

doi:10.22159/ajpcr.2018.v11i11.29383

Authors

Amal A Sulaiman Department of Pharmacology and Therapeutics, Baghdad College for Medical Sciences, Baghdad, Iraq.
Noori M Luaibi Department of Biology, College of Science, Al-Mustansryhia University, Baghdad, Iraq.
Hiba A Qassim Al-Khabeer Private Laboratories for Clinical Analysis, Baghdad, Iraq.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i11.29383

Keywords:

Silver nanoparticles, Thyroid gland, Thyroxine, Thyroid-stimulating hormone

Abstract

Objective: Due to their unique properties, silver nanoparticles (AgNPs) gained a broad utilization in nano-based industries and medicine, which may expose human to increased levels of NPs. However, little is known about their potential harmful effects on endocrine physiology. Hence, this study aimed to investigate the potential dose- and time-dependent outcomes of AgNPs on serum levels of thyroid hormones and thyroid gland histology in female rats.

Methods: A total of 60 female rats were divided into three groups (each of 20 animals), treated with AgNPs for (10, 20, and 30) days. Within each treatment period, animals were assigned into four subgroups each of five rats; control treated with vehicle and the others treated with 12.5, 25, and 50 mg/kg of AgNPs, respectively, by intraperitoneal injection. At the end of treatments, all rats were sacrificed; blood samples were obtained and analyzed for serum levels of T3, T4, and thyroid-stimulating hormone (TSH). Thyroid gland was removed and weighed then kept in buffered formalin solution for microscopic examination.

Results: The data showed a significant increase in the weight of the thyroid gland after 20 and 30 days of the treatment with 50 mg/kg of AgNPs, while the 25 mg/kg dose of AgNps resulted in significant increase only after 30 days. Serum levels of T3 and TSH were nonsignificantly altered by AgNPs in all the treatment groups. Thyroxin levels (T4) were significantly decreased after long-term exposure. Histological specimens of AgNPs treated group showed disturbance of the normal architecture of the thyroid tissue with degeneration of thyroid follicles and desquamated luminal cells.

Conclusion: The results of the current study suggested the possible disrupting potential of long-term exposure to high level of AgNPs on thyroid gland function and histology in female rats.

Downloads

Download data is not yet available.

Author Biography

Amal A Sulaiman, Department of Pharmacology and Therapeutics, Baghdad College for Medical Sciences, Baghdad, Iraq.

Department of pharmacology and therapeutics

References

Kumar P, Roy I. Applications of gold nanoparticles in clinical medicine. Int J Pharm Pharm Sci 2016;8:9-16.

Furtado LM, Bundschuh M, Metcalfe CD. Monitoring the fate and transformation of silver nanoparticles in natural waters. Bull Environ Contam Toxicol 2016;20:20.

Kahru A, Dubourguier HC. From ecotoxicology to nanoecotoxicology. Toxicology 2010;269:105-19.

Garcia T, Lafuente D, Sanchez DJ, Sirvent JJ, Domingo JL, Gomez M. Oral subchronic exposure to silver nanoparticles in rats. Food Chem Toxicol 2016;92:177-87.

Singh M, Manikandan S, Kumaraguru AK. Nanoparticles: A new technology with wide applications. Res J Nanosci Nanotechnol 2010;10:1996-2014.

Jassim AM, Al-Kazaz FF, Kamel LA, Farhan SA, Noori OM. Biochemical study for gold and silver nanoparticles on thyroid hormone levels in sera of patients with chronic renal failure. J Pharm Chem Biol Sci 2015;3:91-103.

Lavado-Autric R, AusÃ³ E, GarcÃa-Velasco JV, Arufe Mdel C, Escobar del Rey F, Berbel P, et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 2003;111:1073-82.

AusÃ³ E, Lavado-Autric R, Cuevas E, Del Rey FE, Morreale De Escobar G, Berbel P, et al. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004;145:4037-47.

Shirband A, Azizian H, Pourentezari M, Rezvani ME, Anvari M, Esmaeilidehaj M. Dose-dependent effects of iron oxide nanoparticles on thyroid hormone concentrations in liver enzymes: Possible tissue destruction. Global J Med Res Stud 2014;1:28-31.

Ribeiro MJ, Maria VL, Scott-Fordsmand JJ, Amorim MJ. Oxidative stress mechanisms caused by Ag nanoparticles (NM300K) are different from those of agNO3: Effects in the soil invertebrate Enchytraeus crypticus. Int J Environ Res Public Health 2015;12:9589-602.

Khanna P, Ong C, Bay BH, Baeg GH. Nanotoxicity: An interplay of oxidative stress, inflammation and cell death. Nanomaterials (Basel) 2015;5:1163-80.

Gharib H, Mayberry WE, Ryan I, Hockert T. Radioimmunoassay for triiodothyronine (T3): Affinity and specificity of the antibody for T3. J Endocrinol 1971;33:509.

Barker SB. Determination of protein bound iodine. J Biol Chem 1948;173:715-24.

Fisher DA. Physiological variations in thyroid hormones: Physiological and pathophysiological considerations. Clin Chem 1996;42:135-9.

Adeyemi OS, Akanji MA. Psidium guajava leaf extract: Effects on rat serum homeostasis and tissue morphology. Comp Clin Pathol 2010;21:401-7.

Elkhawass EA, Mohallal MA, Soliman MF. Acute toxicity of different sizes of silver nanoparticles intraperitoneally injected in BALB/C mice using two toxicological methods. Int J Pharm Pharm Sci 2014;7:94-9.

Soukup T, ZacharovÃ¡ G, Smerdu V, JirmanovÃ¡ I. Body, heart, thyroid gland and skeletal muscle weight changes in rats with altered thyroid status. Physiol Res 2001;50:619-26.

Zoeller TR. Environmental chemicals targeting thyroid. Hormones (Athens) 2010;9:28-40.

Berbel P, Mestre JL, SantamarÃa A, PalazÃ³n I, Franco A, Graells M, et al. Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: The importance of early iodine supplementation. Thyroid 2009;19:511-9.

DeVito M, Biegel L, Brouwer A, Brown S, Brucker-Davis F, Cheek AO, et al. Screening methods for thyroid hormone disruptors. Environ Health Perspect 1999;107:407-15.

Boas M, Feldt-Rasmussen U, Main KM. Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol 2012;355:240-8.

Miller MD, Crofton KM, Rice DC, Zoeller RT. Thyroid-disrupting chemicals: Interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect 2009;117:1033-41.

Hinther A, Vawda S, Skirrow RC, Veldhoen N, Collins P, Cullen JT, et al. Nanometals induce stress and alter thyroid hormone action in Amphibia at or below north American water quality guidelines. Environ Sci Technol 2010;44:8314-21.

Miao W, Zhu B, Xiao X, Li Y, Dirbaba NB, Zhou B, et al. Effects of titanium dioxide nanoparticles on lead bioconcentration and toxicity on thyroid endocrine system and neuronal development in zebrafish larvae. Aquat Toxicol 2015;161:117-26.

AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009;3:279-90.

Kelly GS. Peripheral metabolism of thyroid hormones: A review. Altern Med Rev 2000;5:306-33.

Pavia B, Hagmuller K, Noli MI, Hagmuller K, Zaninovich AA. Evidence suggesting that cadmium induces a non thyroidal illness syndrome in rat. J Endocrinol 1997;154:113-7.

Shirband A, Najafi L, Babadi VY, Beigi-Zarji ME, Najafi A, Mirzakhani F, et al. Effect of iron oxide nanoparticles on thyroid hormones in rats. Appl Chem 2013;56A:13883-5.

Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, et al. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 2010;7:20.

Austin CA, Umbreit TH, Brown KM, Barber DS, Dair BJ, Francke- Carroll S, et al. Distribution of silver nanoparticles in pregnant mice and developing embryos. Nanotoxicology 2012;6:912-22.

Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001;90:1927-36.

Costa CS, Ronconi JV, Daufenbach JF, GonÃ§alves CL, Rezin GT, Streck EL, et al. In vitro effects of silver nanoparticles on the mitochondrial respiratory chain. Mol Cell Biochem 2010;342:51-6.

Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005;19:975-83.

Asharani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 2009;10:65.

Sarhan OM, Hussein RM. Effects of intraperitoneally injected silver nanoparticles on histological structures and blood parameters in the albino rat. Int J Nanomedicine 2014;9:1505-17.

Umbreit TH, Francke-Carroll S, Weaver JL, Miller TJ, Goering PL, Sadrieh N, et al. Tissue distribution and histopathological effects of titanium dioxide nanoparticles after intravenous or subcutaneous injection in mice. J Appl Toxicol 2012;32:350-7.

Gopinath P, Gogoi SK, Sanpui P, Paul A, Chattopadhyay A, Ghosh SS, et al. Signaling gene cascade in silver nanoparticle induced apoptosis. Colloids Surf B Biointerfaces 2010;77:240-5.

Salman RA. The effect of different doses levels of silver nanoparticles (AgNPs) on the kidney and liver in albino male rat. Histopathol Study 2014;11:1503-9.

Hassanin KM, Abd El-Kawi SH, Hashem KS. The prospective protective effect of selenium nanoparticles against chromium-induced oxidative and cellular damage in rat thyroid. Int J Nanomedicine 2013;8:1713-20.